
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Department of Pathology, Mayne Medical School, University of Queensland, Herston, Queensland 4006, Australia [A-E. B-H., M. D. W., J. R. J.]; Mater Medical Research Institute, Mater Misericordiae Hospital, South Brisbane, Queensland 4101, Australia [M. A. M.]; and Conjoint Gastroenterology Laboratory, Royal Brisbane Hospital, Herston QLD 4029, Australia [L. A. S., J. Y., B. A. L.]
Particular mucinous phenotypes have been associated with serrated epithelial polyps of the colon. These polyps also show a high frequency of DNA instability. The aim of this study was to examine the expression of mucins in colorectal cancers that arise through the suppressor and mutator pathways. The immunohistochemical distribution of the human apomucins MUC1, MUC2, MUC4, and MUC5AC was determined in 93 sporadic colorectal cancers classified previously (J. R. Jass et al., J. Clin. Pathol., 52: 455460, 1999) according to levels of DNA microsatellite instability (MSI) as 22 MSI-high (MSI-H), 24 MSI-low (MSI-L), and 47 MS stable (MSS). MUC2 expression was observed in 19 (86%) MSI-H, 10 (42%) MSI-L, and 15 (32%) MSS cancers (P = 0.0001); and MUC5AC expression was observed in 17 (77%) MSI-H, 8 (33%) MSI-L, and 13 (28%) MSS cancers (P = 0.0003). There was no association between MUC1 or MUC4 expression and MSI status. The mucinous phenotype described in serrated polyps (MUC2+/MUC5AC+) was seen in 15 (68%) of 22 MSI-H and only 10 (14%) of 71 MSI-L/MSS cancers (P < 0.0001). Increased expression of the secretory mucins MUC2 and MUC5AC was observed in sporadic MSI-H cancers. Identical mucin changes and DNA MSI occurred in serrated polyps of the colorectum, which suggests that these lesions may represent precursors of MSI-H cancers.
This article has been cited by other articles:
![]() |
A S Mall Analysis of mucins: role in laboratory diagnosis J. Clin. Pathol., September 1, 2008; 61(9): 1018 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. English, J. P. Young, J. A. Simpson, M. A. Jenkins, M. C. Southey, M. D. Walsh, D. D. Buchanan, M. A. Barker, A. M. Haydon, S. G. Royce, et al. Ethnicity and Risk for Colorectal Cancers Showing Somatic BRAF V600E Mutation or CpG Island Methylator Phenotype Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1774 - 1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Lugli, I Zlobec, K Baker, P Minoo, L Tornillo, L Terracciano, and J R Jass Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status J. Clin. Pathol., May 1, 2007; 60(5): 534 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Minoo, K Baker, R Goswami, G Chong, W D Foulkes, A R Ruszkiewicz, M Barker, D Buchanan, J Young, and J R Jass Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis Gut, October 1, 2006; 55(10): 1467 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. You, L.-L. Hsieh, C. R. Changchien, J.-S. Chen, J.-R. Chen, J.-M. Chiang, C. Y. Yeh, P.-S. Hsieh, C.-W. Fan, C.-T. Liu, et al. Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients. Clin. Cancer Res., July 15, 2006; 12(14): 4244 - 4250. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Baker, Y Zhang, C Jin, and J R Jass Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum? J. Clin. Pathol., October 1, 2004; 57(10): 1089 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Higuchi and J R Jass My approach to serrated polyps of the colorectum J. Clin. Pathol., July 1, 2004; 57(7): 682 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Kohlgraf, A. J. Gawron, M. Higashi, J. L. Meza, M. D. Burdick, S. Kitajima, D. L. Kelly, T. C. Caffrey, and M. A. Hollingsworth Contribution of the MUC1 Tandem Repeat and Cytoplasmic Tail to Invasive and Metastatic Properties of a Pancreatic Cancer Cell Line Cancer Res., August 15, 2003; 63(16): 5011 - 5020. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mori, F. M. Selaru, F. Sato, J. Yin, L. A. Simms, Y. Xu, A. Olaru, E. Deacu, S. Wang, J. M. Taylor, et al. The Impact of Microsatellite Instability on the Molecular Phenotype of Colorectal Tumors Cancer Res., August 1, 2003; 63(15): 4577 - 4582. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. J. Whitehall, C. V. A. Wynter, M. D. Walsh, L. A. Simms, D. Purdie, N. Pandeya, J. Young, S. J. Meltzer, B. A. Leggett, and J. R. Jass Morphological and Molecular Heterogeneity within Nonmicrosatellite Instability-High Colorectal Cancer Cancer Res., November 1, 2002; 62(21): 6011 - 6014. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Young, L. A. Simms, K. G. Biden, C. Wynter, V. Whitehall, R. Karamatic, J. George, J. Goldblatt, I. Walpole, S.-A. Robin, et al. Features of Colorectal Cancers with High-Level Microsatellite Instability Occurring in Familial and Sporadic Settings : Parallel Pathways of Tumorigenesis Am. J. Pathol., December 1, 2001; 159(6): 2107 - 2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. David, F. Silva, R. Seruca, M. Pinto, C. Reis, and M. Sobrinho-Simoes Correspondence re: A. E. Biemer-Huttmann et al., Mucin Core Protein Expression in Colorectal Cancers with High Levels of Microsatellite Instability Indicates a Novel Pathway of Morphogenesis. Clin. Cancer Res., 6: 1909-1916, 2000. Clin. Cancer Res., November 1, 2000; 6(11): 4461 - 4462. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |